BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 23460013)

  • 21. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
    Kendall BA; Winthrop KL
    Semin Respir Crit Care Med; 2013 Feb; 34(1):87-94. PubMed ID: 23460008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.
    van Ingen J
    Clin Chest Med; 2015 Mar; 36(1):43-54. PubMed ID: 25676518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report.
    Kuge T; Fukushima K; Matsumoto Y; Abe Y; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Kawasaki T; Matsuki T; Kagawa H; Motooka D; Tsujino K; Miki M; Miki K; Kitada S; Nakamura S; Iida T; Kida H
    BMC Infect Dis; 2020 Nov; 20(1):888. PubMed ID: 33238934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of nontuberculous mycobacterial pulmonary disease.
    Adelman MH; Addrizzo-Harris DJ
    Curr Opin Pulm Med; 2018 May; 24(3):212-219. PubMed ID: 29470253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underlying host risk factors for nontuberculous mycobacterial lung disease.
    Chan ED; Iseman MD
    Semin Respir Crit Care Med; 2013 Feb; 34(1):110-23. PubMed ID: 23460011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 2):S1-25. PubMed ID: 9279284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
    Koh WJ; Stout JE; Yew WW
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.
    Koh WJ; Kwon OJ; Lee KS
    J Korean Med Sci; 2005 Dec; 20(6):913-25. PubMed ID: 16361797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia.
    Eliseev P; Hinderaker SG; Heldal E; Tarasova I; Grjibovski A; Mariandyshev A
    Infect Genet Evol; 2019 Sep; 73():358-361. PubMed ID: 31163274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
    Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
    BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease caused by non-tuberculous mycobacteria: diagnostic procedures and treatment evaluation in the North of Buenos Aires Province.
    Imperiale B; Zumárraga M; Gioffré A; Di Giulio B; Cataldi A; Morcillo N
    Rev Argent Microbiol; 2012; 44(1):3-9. PubMed ID: 22610284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nontuberculous mycobacterial ocular and adnexal infections.
    Moorthy RS; Valluri S; Rao NA
    Surv Ophthalmol; 2012; 57(3):202-35. PubMed ID: 22516536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of nontuberculous mycobacterial infections.
    van Ingen J
    Semin Respir Crit Care Med; 2013 Feb; 34(1):103-9. PubMed ID: 23460010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.
    Larsson LO; Polverino E; Hoefsloot W; Codecasa LR; Diel R; Jenkins SG; Loebinger MR
    Expert Rev Respir Med; 2017 Dec; 11(12):977-989. PubMed ID: 28967797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.